***AMAZING INVESTMENT OPPORTUNITY***
At this point, getting Prolanta though phase I is just a formality. Prolanta is 99% the same drug as Somavert. If you want to get an idea of how we will perform in phase I, go look at the Somavert trials. The only question that matters and it is what we will find out from completing 2-3 trial phases is: Does antagonizing human prolactin receptors result in an effective cancer treatment as either a monotherapy or combination therapy with chemo?
Based on the data and research, it's pretty much a given that Prolanta will be an effective antagonist, and Dr Wen Chen has already demonstrated that G129R is a pure hPRL receptor antagonist. Does a pure prolactin receptor antagonist actually treat cancer? I don't think it's a coincidence that doctors and scientists have been trying to find an effective way to antagonize human prolactin for the past 20-30 years. They know it plays a major role in many cancers. G129R is the only pure antagonist being developed at the moment. Knowing how effective Somavert is at antagonizing hGH and how similar and related hGH is to hPRL, and that Prolanta is essentially the same drug as Somavert, the odds are pretty good here.
IMO
